article thumbnail

Moody's: Hospitals, staffing agencies shouldering the labor shortage while insurers are largely immune

Fierce Healthcare

Moody's: Hospitals, staffing agencies shouldering the labor shortage while insurers are largely immune. Mon, 10/25/2021 - 13:05.

article thumbnail

Early data shows Russia’s Sputnik V COVID-19 vaccine produces immune response

pharmaphorum

A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety. For our vaccine, we use two different adenovirus vectors in a bid to avoid the immune system becoming immune to the vector.”.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hospital Universitario and Josep Carreras develop cell therapy for leukaemia

Pharmaceutical Technology

Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia. The post Hospital Universitario and Josep Carreras develop cell therapy for leukaemia appeared first on Pharmaceutical Technology.

Hospitals 110
article thumbnail

Nonprofit hospitals aren't immune to FTC's noncompete ban, lawyers, Fitch analysts say

Fierce Healthcare

More broadly, nonprofit hospitals—particularly small and rural facilities—are likely to face higher wages and potential operational disruption should the ban survive the courts, Fitch Ratings analysts warn.

article thumbnail

A Comprehensive Approach to Outsourcing Cybersecurity

Fierce Healthcare

Smaller healthcare organizations, such as regional hospitals, nursing homes, rehab centers and clinics, are not immune from cyberattacks and data breaches. Smaller healthcare organizations, such as regional hospitals, nursing homes, rehab centers and clinics, are not immune from cyberattacks and data breaches.

article thumbnail

STAT+: Hospitals struggle to make money on CAR-T cancer therapies, but their fortunes may change

STAT

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. CAR-T uses the body’s own immune system to kill cancerous cells. Continue to STAT+ to read the full story…

article thumbnail

NIH kicks off COVID-19 immune modulator trial

Outsourcing Pharma

The US agency has launched a large clinical trial to examine the viability of using immune modulators to treat patients hospitalized with COVID-19.